27904925|t|Breaking sitting with light activities vs structured exercise: a randomised crossover study demonstrating benefits for glycaemic control and insulin sensitivity in type 2 diabetes
27904925|a|We aimed to examine the effects of breaking sitting with standing and light-intensity walking vs an energy -matched bout of structured exercise on 24 h glucose levels and insulin resistance in patients with type 2 diabetes. In a randomised crossover study, 19 patients with type 2 diabetes (13 men /6 women, 63 ± 9 years old) who were not using insulin each followed three regimens under free-living condition s, each lasting 4 days: (1) Sitting: 4415 steps / day with 14 h sitting / day; (2) Exercise: 4823 steps / day with 1.1 h/ day of sitting replaced by moderate - to vigorous-intensity cycling (at an intensity of 5.9 metabolic equivalents [METs]); and (3) Sit Less: 17,502 steps / day with 4.7 h/ day of sitting replaced by standing and light-intensity walking (an additional 2.5 h and 2.2 h, respectively, compared with the hours spent doing these activities in the Sitting regimen). Blocked randomisation was performed using a block size of six regimen orders using sealed, non-translucent envelopes. Individuals who assessed the outcomes were blinded to group assignment. Meals were standardised during each intervention. Physical activity and glucose levels were assessed for 24 h/ day by accelerometry (activPAL) and a glucose monitor (iPro2), respectively. The incremental AUC (iAUC) for 24 h glucose (primary outcome) and insulin resistance (HOMA2-IR) were assessed on days 4 and 5, respectively. The iAUC for 24 h glucose (mean ± SEM) was significantly lower during the Sit Less intervention than in Sitting (1263 ± 189 min × mmol/l vs 1974 ± 324 min × mmol/l; p = 0.002), and was similar between Sit Less and Exercise (Exercise: 1383 ± 194 min × mmol/l; p = 0.499). Exercise failed to improve HOMA2-IR compared with Sitting (2.06 ± 0.28 vs 2.16 ± 0.26; p = 0.177). In contrast, Sit Less (1.89 ± 0.26) significantly reduced HOMA2-IR compared with Exercise (p = 0.015) as well as Sitting (p = 0.001). Breaking sitting with standing and light-intensity walking effectively improved 24 h glucose levels and improved insulin sensitivity in individuals with type 2 diabetes to a greater extent than structured exercise. Thus, our results suggest that breaking sitting with standing and light-intensity walking may be an alternative to structured exercise to promote glycaemic control in patients type 2 diabetes. Clinicaltrials.gov NCT02371239 FUNDING:: The study was supported by a Kootstra grant from Maastricht University Medical Centre(+), and the Dutch Heart Foundation. Financial support was also provided by Novo Nordisk BV, and Medtronic and Roche made the equipment available for continuous glucose monitoring.
27904925	0	16	Breaking sitting	T039	C2584297
27904925	22	38	light activities	T052	C0441655
27904925	42	61	structured exercise	T056	C0015259
27904925	65	91	randomised crossover study	T062	C0150097
27904925	106	114	benefits	T081	C0814225
27904925	119	136	glycaemic control	T061	C3267174
27904925	141	160	insulin sensitivity	T046	C0920563
27904925	164	179	type 2 diabetes	T047	C0011860
27904925	204	214	effects of	T080	C1704420
27904925	224	231	sitting	T039	C2584297
27904925	237	245	standing	T082	C0231472
27904925	250	273	light-intensity walking	T056	C0080331
27904925	280	286	energy	T081	C1442080
27904925	304	323	structured exercise	T056	C0015259
27904925	332	346	glucose levels	T034	C0428548
27904925	351	369	insulin resistance	T046	C0021655
27904925	373	381	patients	T101	C0030705
27904925	387	402	type 2 diabetes	T047	C0011860
27904925	409	435	randomised crossover study	T062	C0150097
27904925	440	448	patients	T101	C0030705
27904925	454	469	type 2 diabetes	T047	C0011860
27904925	474	477	men	T098	C0025266
27904925	481	486	women	T098	C0043210
27904925	495	500	years	T079	C1510829
27904925	525	532	insulin	T116,T121,T125	C0021641
27904925	553	561	regimens	T061	C0040808
27904925	568	589	free-living condition	T080	C0337645
27904925	608	612	days	T079	C0439228
27904925	618	625	Sitting	T039	C2584297
27904925	632	637	steps	T081	C3814463
27904925	640	643	day	T079	C0439228
27904925	654	661	sitting	T039	C2584297
27904925	664	667	day	T079	C0439228
27904925	673	681	Exercise	T056	C0015259
27904925	688	693	steps	T081	C3814463
27904925	696	699	day	T079	C0439228
27904925	712	715	day	T079	C0439228
27904925	719	726	sitting	T039	C2584297
27904925	739	747	moderate	T080	C0205081
27904925	753	779	vigorous-intensity cycling	T056	C0026606
27904925	787	796	intensity	T080	C0522510
27904925	804	825	metabolic equivalents	T081	C1552986
27904925	827	831	METs	T081	C1552986
27904925	843	851	Sit Less	T061	C0184661
27904925	860	865	steps	T081	C3814463
27904925	868	871	day	T079	C0439228
27904925	884	887	day	T079	C0439228
27904925	891	898	sitting	T039	C2584297
27904925	911	919	standing	T082	C0231472
27904925	924	947	light-intensity walking	T056	C0080331
27904925	1012	1017	hours	T079	C0439227
27904925	1036	1046	activities	T052	C0441655
27904925	1054	1061	Sitting	T039	C2584297
27904925	1062	1069	regimen	T061	C0040808
27904925	1072	1093	Blocked randomisation	T062	C0034656
27904925	1098	1107	performed	T169	C0884358
27904925	1116	1126	block size	T082	C0456389
27904925	1134	1141	regimen	T061	C0040808
27904925	1190	1201	Individuals	T098	C0237401
27904925	1206	1214	assessed	T052	C1516048
27904925	1219	1227	outcomes	T080	C0085415
27904925	1233	1240	blinded	T062	C0150108
27904925	1244	1249	group	T078	C0441833
27904925	1250	1260	assignment	T169	C1516050
27904925	1262	1267	Meals	T056	C1998602
27904925	1273	1285	standardised	T080	C0597996
27904925	1298	1310	intervention	T058	C1273869
27904925	1312	1329	Physical activity	T056	C0026606
27904925	1334	1348	glucose levels	T034	C0428548
27904925	1354	1362	assessed	T052	C1516048
27904925	1373	1376	day	T079	C0439228
27904925	1380	1393	accelerometry	T060	C0441677
27904925	1395	1403	activPAL	T060	C0430022
27904925	1411	1434	glucose monitor (iPro2)	T074	C0025080
27904925	1454	1465	incremental	T081	C1705117
27904925	1466	1469	AUC	T081	C0376690
27904925	1471	1475	iAUC	T081	C0376690
27904925	1486	1493	glucose	T109,T121,T123	C0017725
27904925	1495	1510	primary outcome	T080	C3274433
27904925	1516	1534	insulin resistance	T046	C0021655
27904925	1536	1544	HOMA2-IR	T046	C0021655
27904925	1551	1559	assessed	T052	C1516048
27904925	1563	1567	days	T079	C0439228
27904925	1595	1599	iAUC	T081	C0376690
27904925	1609	1616	glucose	T109,T121,T123	C0017725
27904925	1634	1653	significantly lower	T081	C4055638
27904925	1665	1686	Sit Less intervention	T061	C0184661
27904925	1695	1702	Sitting	T039	C2584297
27904925	1792	1800	Sit Less	T061	C0184661
27904925	1805	1813	Exercise	T056	C0015259
27904925	1815	1823	Exercise	T056	C0015259
27904925	1862	1870	Exercise	T056	C0015259
27904925	1889	1897	HOMA2-IR	T046	C0021655
27904925	1912	1919	Sitting	T039	C2584297
27904925	1974	1982	Sit Less	T061	C0184661
27904925	2011	2018	reduced	T080	C0392756
27904925	2019	2027	HOMA2-IR	T046	C0021655
27904925	2042	2050	Exercise	T056	C0015259
27904925	2074	2081	Sitting	T039	C2584297
27904925	2095	2111	Breaking sitting	T039	C2584297
27904925	2117	2125	standing	T082	C0231472
27904925	2130	2153	light-intensity walking	T056	C0080331
27904925	2180	2194	glucose levels	T034	C0428548
27904925	2199	2207	improved	T033	C0184511
27904925	2208	2227	insulin sensitivity	T046	C0920563
27904925	2231	2242	individuals	T098	C0237401
27904925	2248	2263	type 2 diabetes	T047	C0011860
27904925	2289	2308	structured exercise	T056	C0015259
27904925	2320	2327	results	T169	C1274040
27904925	2341	2357	breaking sitting	T039	C2584297
27904925	2363	2371	standing	T082	C0231472
27904925	2376	2399	light-intensity walking	T056	C0080331
27904925	2425	2444	structured exercise	T056	C0015259
27904925	2456	2473	glycaemic control	T061	C3267174
27904925	2477	2485	patients	T101	C0030705
27904925	2486	2501	type 2 diabetes	T047	C0011860